Eptifibatide Chemical Structure (Image 01)
Eptifibatide Injection
Product Images NDC 0338-9558
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 0338-9558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Kaplan-meier Plot Of Time To Death Or Myocardial Infarction Within 30 Days Of Randomization In The Pursuit Study (Image 02)
Representative Container Label Ndc 0338-9559-10 (Image 03)
Description: Atide Injection is a medication available in a 75 mg per 100 mL strength for intravenous use. It is manufactured by Baxter and the prescription must be adjusted by a medical professional. There are some precautions and limitations to the administration of this medication. The provided information does not offer any further context or details.*
Representative Carton Label 0338-9558-10 (Image 04)
Eptifibatide Injection is a medication that comes in a 75 mg per 100 mL solution (0.75 mg/mL) for intravenous infusion only. The content should not be compounded. The carton should be used for protection. The medication is not for intravenous bolus use. It is important to read the prescribing information. Non-English characters are present in the text, but do not provide any relevant information.*
Representative Shipper Label For Serialization (Image 05)
Eptifibatide Injection is a medication that comes in the form of a 75 mg per 100 mL solution provided in 12 single-dose containers named GALAXY. The product is identified by the NDC code 0338-9558-10 and 263476. It is recommended to store the medication at a temperature between 2 to 8°C (36-46°F) and may be transferred to a controlled room temperature of up to 25°C (77°F) for a maximum period of 2 months. If not used within 2 months of transfer, the product should be discarded.*
Representative Shipper Label For Serialization Panel 2 Of 2 (Image 06)
This is a description of Eptifibatide Injection. It comes in packs of 12 x 100mL GALAXY Single-Dose Containers with a strength of 75mg per 100mL (0.75 mg/mL). It is only available with a prescription and must be stored in a refrigerator between 2-8% (36-46°). It can be stored at 0 to 25°C (77°F; USP Controlled Room Temperature) for up to 2 months after transfer. If it is not used within 2 months of transfer, it must be discarded.*
Representative Container Label Ndc 0338-9559-20 (Image 07)
Product name: ptifibatide Injection. This product contains 200 mg of the active ingredient per 100 mL, with a concentration of 2mg/mL. It is labeled with a barcode and various identification numbers, including Codo 263477. The bottle appears to be manufactured by Baxter, although it is unclear what the accompanying text says. There are also some instructions and warnings regarding handling and administration of the product.*
Representative Carton Label 0338-9559-20 (Image 08)
This is not-available as the text seems to be a random combination of numbers, letters, and symbols without any coherence or meaningful information.*
Representative Shipper Label 0338-9559-20 For Serialization Panel 1 Of 2 (Image 09)
Eptifibatide Injection is a prescription drug that is available in a package containing twelve single-dose containers. Each container contains 200mg of the drug and 100mL of solution. The drug must be stored at a temperature of 36-46 degrees Fahrenheit and should be discarded if not used within two months of transfer. The drug is approved only for prescription use and should not be used without a doctor's recommendation.*
Representative Shipper Label For Serialization 0338-9559-20 Panel 2 Of 2 (Image 10)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
